Benedikt Fels

Ratzeburger Allee 160
Luebeck, SH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Terminal complement inhibition is associated with renal, hematologic, and thrombotic complications during septic shock: A global propensity score-matched cohort study.

Terminal complement inhibition is associated with renal, hematologic, and thrombotic complications during septic shock: A global propensity score-matched cohort study.

Journal: Journal of critical care

Published: June 04, 2026

Complement C5 inhibition in generalized myasthenia gravis is associated with improved survival and increased cardiovascular risk.

Complement C5 inhibition in generalized myasthenia gravis is associated with improved survival and increased cardiovascular risk.

Journal: Frontiers in immunology

Published: February 17, 2026

Activation of the C3a-C3aReceptor-axis is associated with endothelial dysfunction and glycocalyx damage in ST-elevation myocardial infarction.

Activation of the C3a-C3aReceptor-axis is associated with endothelial dysfunction and glycocalyx damage in ST-elevation myocardial infarction.

Journal: Basic research in cardiology

Published: December 12, 2025

Empagliflozin-mediated protection of heparan sulfate-rich endothelial glycocalyx during vascular inflammation.

Empagliflozin-mediated protection of heparan sulfate-rich endothelial glycocalyx during vascular inflammation.

Journal: Biochemical pharmacology

Published: November 24, 2025

Empagliflozin-mediated protection of heparan sulfate-rich endothelial glycocalyx during vascular inflammation.

Empagliflozin-mediated protection of heparan sulfate-rich endothelial glycocalyx during vascular inflammation.

Journal: Biochemical pharmacology

Published: November 24, 2025

Amlodipine improves aortic dysfunction in atherosclerotic mice.

Amlodipine improves aortic dysfunction in atherosclerotic mice.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 08, 2025

The anti-atherosclerotic effect of chronic AT1 receptor blocker treatment also depends on the ACE2/Ang(1-7)/Mas axis.

The anti-atherosclerotic effect of chronic AT1 receptor blocker treatment also depends on the ACE2/Ang(1-7)/Mas axis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 16, 2025

SECS, drugs, and Rac1&Rho: regulation of EnNaC in vascular endothelial cells.

SECS, drugs, and Rac1&Rho: regulation of EnNaC in vascular endothelial cells.

Journal: Pflugers Archiv : European journal of physiology

Published: October 25, 2024

Dysregulated autoantibodies targeting AGTR1 are associated with the accumulation of COVID-19 symptoms.

Dysregulated autoantibodies targeting AGTR1 are associated with the accumulation of COVID-19 symptoms.

Journal: NPJ systems biology and applications

Published: May 09, 2024

Dysregulated complement activation during acute myocardial infarction leads to endothelial glycocalyx degradation and endothelial dysfunction via the C5a:C5a-Receptor1 axis.

Dysregulated complement activation during acute myocardial infarction leads to endothelial glycocalyx degradation and endothelial dysfunction via the C5a:C5a-Receptor1 axis.

Journal: Frontiers in immunology

Published: May 01, 2024

Piezo1-induced durotaxis of pancreatic stellate cells depends on TRPC1 and TRPV4 channels.

Piezo1-induced durotaxis of pancreatic stellate cells depends on TRPC1 and TRPV4 channels.

Journal: Journal of cell science

Published: April 26, 2024

Piezo1-induced durotaxis of pancreatic stellate cells depends on TRPC1 and TRPV4 channels.

Piezo1-induced durotaxis of pancreatic stellate cells depends on TRPC1 and TRPV4 channels.

Journal: bioRxiv : the preprint server for biology

Published: January 08, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026